These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30242575)

  • 1. General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice Experiment.
    Najafzadeh M; Schneeweiss S; Choudhry NK; Avorn J; Gagne JJ
    Patient; 2019 Apr; 12(2):235-246. PubMed ID: 30242575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' preferences in anticoagulant therapy: discrete choice experiment.
    Najafzadeh M; Gagne JJ; Choudhry NK; Polinski JM; Avorn J; Schneeweiss SS
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):912-9. PubMed ID: 25387782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment.
    Pinto CA; Chua GN; Bridges JFP; Brookes E; Hyacinthe J; Tervonen T
    Patient; 2022 Mar; 15(2):255-266. PubMed ID: 34569030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment.
    Zhao J; Wang H; Li X; Hu Y; Yan VKC; Wong CKH; Guo Y; Cheung MKH; Lip GYH; Siu CW; Tse HF; Chan EW
    PLoS Med; 2021 Aug; 18(8):e1003730. PubMed ID: 34437553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese Patients' and Physicians' Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment.
    Okumura K; Inoue H; Yasaka M; Gonzalez JM; Hauber AB; Levitan B; Yuan Z; Baptiste Briere J
    J Health Econ Outcomes Res; 2015; 2(2):207-220. PubMed ID: 37663581
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives.
    Yuan Z; Levitan B; Burton P; Poulos C; Brett Hauber A; Berlin JA
    Curr Med Res Opin; 2014 Sep; 30(9):1733-41. PubMed ID: 24827068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining Criteria and Weights for Prioritizing Health Technologies Based on the Preferences of the General Population: A New Zealand Pilot Study.
    Sullivan T; Hansen P
    Value Health; 2017 Apr; 20(4):679-686. PubMed ID: 28408011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis.
    DiSantostefano RL; Simons G; Englbrecht M; Humphreys JH; Bruce IN; Bywall KS; Radawski C; Raza K; Falahee M; Veldwijk J
    Med Decis Making; 2024 Feb; 44(2):189-202. PubMed ID: 38240281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies.
    Fairchild AO; Reed SD; Gonzalez JM
    Med Decis Making; 2023 Feb; 43(2):227-238. PubMed ID: 36326189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
    Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
    Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
    Janssen EM; Hauber AB; Bridges JFP
    Value Health; 2018 Jan; 21(1):59-68. PubMed ID: 29304942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan.
    Okumura K; Inoue H; Yasaka M; Gonzalez JM; Hauber AB; Levitan B; Yuan Z; Briere JB
    Value Health Reg Issues; 2015 May; 6():65-72. PubMed ID: 29698195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculating Preference Weights for the Labor and Delivery Index: A Discrete Choice Experiment on Women's Birth Experiences.
    Gärtner FR; de Bekker-Grob EW; Stiggelbout AM; Rijnders ME; Freeman LM; Middeldorp JM; Bloemenkamp KW; de Miranda E; van den Akker-van Marle ME
    Value Health; 2015 Sep; 18(6):856-64. PubMed ID: 26409614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
    Vass CM; Rigby D; Payne K
    Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences and willingness to pay for different options of anticoagulant therapy.
    Moia M; Mantovani LG; Carpenedo M; Scalone L; Monzini MS; Cesana G; Mannucci PM
    Intern Emerg Med; 2013 Apr; 8(3):237-43. PubMed ID: 22926743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting patients' preferences for epilepsy diagnostics: a discrete choice experiment.
    Wijnen BF; de Kinderen RJ; Colon AJ; Dirksen CD; Essers BA; Hiligsmann M; Leijten FS; Ossenblok PP; Evers SM
    Epilepsy Behav; 2014 Feb; 31():102-9. PubMed ID: 24389020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.